NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Development of control material for hemoglobin analysis.

Author(s): Pornprasert S, Kongthai K, Waneesorn J, Jaiping K, Treesuwan K

Publication: Clin Chem Lab Med, 2012, Vol. 50, Page 351-356

PubMed ID: 22070221 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of lyophilization and duration of frozen storage of lyophilized erythrocytes on the levels of adult hemoglobin (HbA), HbA2/variant E (E) and fetal hemoglobin (HbF) in healthy individuals and patients with beta-thalassemia.

Conclusion of Paper

Lyophilized hemoglobin stored at -20 degrees C for up to 3 months had similar chromatograms and only insignificant changes in the percentages of HbA, HbA2/E, and HbF from those observed in the refrigerated specimens prior to lyophilization, regardless of patient diagnosis. Strong correlations in HbA, HbA2/E, and HbF levels between the three technology platforms were observed.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of lyophilization, duration of storage of lyophilized erythrocytes at -20 degrees C, and method of analysis on the levels of HbA, HbA2/E, and HbF in blood from healthy individuals and those with beta-thalassemia. EDTA-blood was collected and stored at 4 degrees C for up to 3 days prior to analysis by HPLC. Packed red blood cells were prepared at 4 degrees C, lyophilized, and stored at -20 degrees C. After storage, the cells were reconstituted with distilled water.

    Summary of Findings:

    Lyophilized hemoglobin stored at -20 degrees C for up to 3 months had similar chromatograms and only insignificant changes in the percentages of HbA, HbA2/E, and HbF from those observed in the refrigerated specimens prior to lyophilization, regardless of patient diagnosis. Strong correlations in HbA, HbA2/E, and HbF levels between the three technology platforms were observed (all three r>0.99).

    Biospecimens
    Preservative Types
    • Other Preservative
    • Frozen
    Diagnoses:
    • Normal
    • Other diagnoses
    Platform:
    AnalyteTechnology Platform
    Protein HPLC
    Protein Low pressure liquid chromatography (LPLC)
    Protein Capillary electrophoresis-MS
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Preaquisition Diagnosis/ patient condition Beta thalessemia
    Normal
    Biospecimen Preservation Type of fixation/preservation Frozen
    Lyophilized
    Refrigeration
    Storage Storage duration 1 day
    15 days
    30 days
    3 months
    HPLC Specific Technology platform Capillary electrophoresis
    Low pressure liquid chromatography

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...